Clinical Trial Update: Botulinum-A Toxin Injection for Detrusor Hyperreflexia in Spinal Cord Injury: A Non-Surgical Approach. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating botulinum toxin type A injections for detrusor hyperreflexia in spinal cord injury was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Overactive Bladder, Urinary Incontinence | Phase 2 | Status: WITHDRAWN